Evotec SE
As of Oct 23, 2026 close
- Market cap
- $266.51M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.33$4.27
- Volume (live)
- -
- Avg. volume (3M)
- 156.90K
Evotec SE (EVO) Stock Price & Financial Analysis
Evotec SE Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.50 - $1.53 |
|---|---|
| 52-Week High | $4.27 |
| 52-Week Low | $1.33 |
| Open | $1.50 |
| Volume (last close) | 20.57K |
| Average Volume (3M) | 156.90K |
| Revenue (TTM) | 903.16M |
|---|---|
| Net Income (TTM) | -158.36M |
| Free Cash Flow (TTM) | -31.39M |
| EPS (TTM) | −$0.51 |
| Profit Margin | -17.53% |
| Operating Margin | -10.46% |
| Return on Equity (ROE) | -21.26% |
| Debt to Equity | 0.71 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Jan 11, 2019 |
| Market Cap | 266.51M |
|---|---|
| Shares Outstanding | 177.67M |
| Price to Sales (P/S) | 0.30 |
| Price to Book (P/B) | 0.36 |
| EV/EBITDA | -7.04 |
| 50-Day MA | $1.72 |
|---|---|
| 200-Day MA | $2.60 |
| 1-Year Change | −61.88% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Evotec SE at a Glance
As of the Oct 23, 2026 close, Evotec SE (EVO) has a market capitalization of $266.51M. The stock trades at 0.3× sales. Over the trailing twelve months it lost $158.36M on revenue of $903.16M and burned $31.39M of free cash flow. Revenue grew 6.3% year over year.
As of its latest reported balance sheet, it holds $389.93M in cash and securities against $532.65M of debt, a net debt position of $142.73M.
Evotec SE does not currently pay a dividend.
The share price is down 61.9% over the past year. At $1.50 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $1.33 to $4.27, below its 200-day moving average of $2.60.
Frequently Asked Questions About Evotec SE
What is the current stock price for EVO?
As of the Oct 23, 2026 close, EVO stock trades at $1.50. The 52-week range is $1.33–$4.27, with a day range of $1.50–$1.53.
What is the P/E ratio for EVO?
The P/E ratio (Price-to-Earnings) for EVO is shown in the Key Statistics section. This valuation metric helps compare Evotec SE to industry peers.
Does EVO pay dividends?
Evotec SE does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for EVO?
Analyst ratings and recommendations for EVO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of EVO?
As of the Oct 23, 2026 close, Evotec SE's market capitalization is $266.5M, classifying it as a micro-cap company. Evotec SE operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.